ZINC NEUROTOXICITY
锌的神经毒性
基本信息
- 批准号:6639439
- 负责人:
- 金额:$ 34.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-09-30 至 2005-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (From the Applicant's Abstract): Glutamate receptor- and
Ca2+-mediated neurotoxicity was the focus of study during past grant periods.
Recently, we have begun to examine a related form of neurotoxicity, also
enhanced by glutamate receptor activation but mediated by Zn2+ rather than
Ca2+. Zn2+-mediated neurotoxicity likely contributes to central neuronal death
after certain insults, such as transient global ischemia. Our Central
Hypothesis is that extracellular Zn2+ can kill neurons by: 1) entering across
the plasma membrane, largely through voltage-gated Ca2+ channels (VGCCs) in
depolarized neurons; 2) increasing intracellular free Zn2+ ([Zn2+]i); 3)
interfering with glycolysis, causing ATP levels to fall; 4) triggering
apoptosis (at lower Zn2+ levels). The proposed experiments will test aspects of
this central hypothesis in cultured murine cortical neurons, delineating
mechanisms underlying Zn2+-induced neuronal death to advance efforts to develop
therapeutic countermeasures that might be used to reduce brain damage after
cardiac arrest.
Cultured neurons will be exposed to varying concentrations of extracellular
zinc for brief ("fast toxicity") or prolonged ("slow toxicity") time periods.
We plan to define the relationships linking transmembrane Zn2+ influx (measured
with patch-clamp and radio-isotope flux techniques), [Zn2+]I (measured with dye
videomacroscopy), cellular Zn2+ content (measured with atomic absorption
spectroscopy or inductively-coupled plasma spectroscopy), and cellular
apoptosis (v.s. necrosis). We will also measure resultant neuronal levels of
ATP, NAD+, NADH and glycolytic intermediates, mitochondrial transmembrane
potential, and cytoplasmic reactive oxygen species (measured with
dihydroethidium dye). Finally, we will test genetic perturbations of cellular
Zn2+ homeostasis, specifically increased or decreased expression of the key
plasma membrane Zn2+ transporter, ZnT-1, or the major neuronal intracellular
Zn2+ binding protein, metallothionein-III, will produce the changes in
vulnerability to Zn2+ neurotoxicity predicted by the central hypothesis.
描述(来自申请人的摘要):谷氨酸受体-和
钙离子介导的神经毒性是过去研究的重点。
最近,我们也开始研究一种相关的神经毒性,
增强谷氨酸受体激活,但介导的锌2+,而不是
Ca2+。Zn 2+介导的神经毒性可能导致中枢神经元死亡
在某些损伤后,例如短暂的全脑缺血。我们的中央
假设细胞外Zn 2+可以通过以下方式杀死神经元:1)进入跨膜细胞,
质膜,主要是通过电压门控钙通道(VGCC),
去极化神经元; 2)增加细胞内游离Zn 2+([Zn 2 +]i); 3)
干扰糖酵解,导致ATP水平下降; 4)触发
细胞凋亡(在较低的Zn 2+水平)。拟议的实验将测试以下方面:
在培养的小鼠皮层神经元中,
Zn 2+诱导的神经元死亡的潜在机制,以促进开发
治疗对策,可用于减少脑损伤后,
心脏骤停
培养的神经元将暴露于不同浓度的细胞外
锌短期(“快速毒性”)或长期(“缓慢毒性”)的时间段。
我们计划定义跨膜Zn 2+流入(测量)
用膜片钳和放射性同位素通量技术),[Zn 2 +]I(用染料
视频显微镜),细胞Zn 2+含量(用原子吸收法测量
光谱学或电感耦合等离子体光谱学),以及细胞
细胞凋亡(v.s.坏死)。我们还将测量由此产生的神经元水平
ATP、NAD+、NADH和糖酵解中间产物,线粒体跨膜
电位和细胞质活性氧(用
二氢乙锭染料)。最后,我们将测试细胞的遗传扰动,
锌2+稳态,特别是增加或减少表达的关键
质膜Zn 2+转运蛋白,ZnT-1,或主要的神经细胞内
Zn ~(2+)结合蛋白-金属硫蛋白-Ⅲ(metallothionein-III)会引起
脆弱性锌+神经毒性预测的中心假说。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTIAN Thomas SHELINE其他文献
CHRISTIAN Thomas SHELINE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTIAN Thomas SHELINE', 18)}}的其他基金
Type-1 Diabetes: Zn2+ Potentiated Beta-Cell Death By Sirtuin-Mediated NAD+ Loss
1 型糖尿病:Sirtuin 介导的 NAD 损失导致 Zn2 增强 β 细胞死亡
- 批准号:
7998878 - 财政年份:2010
- 资助金额:
$ 34.65万 - 项目类别:
Type-1 Diabetes: Zn2+ Potentiated Beta-Cell Death By Sirtuin-Mediated NAD+ Loss
1 型糖尿病:Sirtuin 介导的 NAD 损失导致 Zn2 增强 β 细胞死亡
- 批准号:
7624970 - 财政年份:2006
- 资助金额:
$ 34.65万 - 项目类别:
Type-1 Diabetes: Zn2+ Potentiated Beta-Cell Death By Sirtuin-Mediated NAD+ Loss
1 型糖尿病:Sirtuin 介导的 NAD 损失导致 Zn2 增强 β 细胞死亡
- 批准号:
7393678 - 财政年份:2006
- 资助金额:
$ 34.65万 - 项目类别:
Type-1 Diabetes: Zn2+ Potentiated Beta-Cell Death By
1 型糖尿病:Zn2 增强 β 细胞死亡
- 批准号:
7143563 - 财政年份:2006
- 资助金额:
$ 34.65万 - 项目类别:
Type-1 Diabetes: Zn2+ Potentiated Beta-Cell Death By Sirtuin-Mediated NAD+ Loss
1 型糖尿病:Sirtuin 介导的 NAD 损失导致 Zn2 增强 β 细胞死亡
- 批准号:
7248822 - 财政年份:2006
- 资助金额:
$ 34.65万 - 项目类别:
Type-1 Diabetes: Zn2+ Potentiated Beta-Cell Death By Sirtuin-Mediated NAD+ Loss
1 型糖尿病:Sirtuin 介导的 NAD 损失导致 Zn2 增强 β 细胞死亡
- 批准号:
7741877 - 财政年份:2006
- 资助金额:
$ 34.65万 - 项目类别:
CLONING OF AND REQUIREMENT FOR TAR BINDING PROTEIN TRP-1
焦油结合蛋白TRP-1的克隆和要求
- 批准号:
2059039 - 财政年份:1993
- 资助金额:
$ 34.65万 - 项目类别:
相似海外基金
Regulation of GluN2B-NMDA Receptors by Interactions with the Actin Cytoskeleton
通过与肌动蛋白细胞骨架相互作用调节 GluN2B-NMDA 受体
- 批准号:
10606121 - 财政年份:2023
- 资助金额:
$ 34.65万 - 项目类别:
Network activity and the role of NMDA receptors in associative learning
网络活动和 NMDA 受体在联想学习中的作用
- 批准号:
DP220102377 - 财政年份:2022
- 资助金额:
$ 34.65万 - 项目类别:
Discovery Projects
Non-canonical signaling by NMDA receptors in the Fragile X brain
脆性 X 脑中 NMDA 受体的非规范信号传导
- 批准号:
464946 - 财政年份:2022
- 资助金额:
$ 34.65万 - 项目类别:
Operating Grants
Exploring the mysterious role of astrocytic NMDA receptors from behavioural to biochemical levels.
从行为到生化水平探索星形细胞NMDA受体的神秘作用。
- 批准号:
547576-2020 - 财政年份:2022
- 资助金额:
$ 34.65万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Cocaine-induced adaptation in NMDA receptors
可卡因诱导的 NMDA 受体适应
- 批准号:
10472185 - 财政年份:2022
- 资助金额:
$ 34.65万 - 项目类别:
Precision Targeting of Heteromeric NMDA Receptors in Age-Related Memory Disorders
异聚 NMDA 受体在年龄相关记忆障碍中的精确靶向
- 批准号:
10624058 - 财政年份:2022
- 资助金额:
$ 34.65万 - 项目类别:
Molecular pathways connecting NMDA receptors to the actin cytoskeleton
连接 NMDA 受体与肌动蛋白细胞骨架的分子途径
- 批准号:
RGPIN-2018-06409 - 财政年份:2022
- 资助金额:
$ 34.65万 - 项目类别:
Discovery Grants Program - Individual
Extrasynaptic NMDA receptors and resilience to chronic stress
突触外 NMDA 受体和慢性应激恢复能力
- 批准号:
462065 - 财政年份:2022
- 资助金额:
$ 34.65万 - 项目类别:
Operating Grants














{{item.name}}会员




